{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T09:08:32Z","timestamp":1793869712337,"version":"4.6.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of the Report:<\/jats:title>\n                    <jats:p>The PRIMARY score standardizes interpretation of PSMA PET for intraprostatic assessment of clinically significant prostate cancer (csPCa). Although early studies are promising, no meta-analysis has systematically evaluated its accuracy. We aimed to assess the diagnostic performance of PRIMARY and compare it with PI-RADS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis were performed according to PRISMA-DTA guidelines. Studies assessing the PRIMARY score on PSMA PET\/CT or PET\/MRI for csPCa detection were included. The primary analysis focused on biopsy-na\u00efve patients; secondary analyses incorporated all studies irrespective of prior histology, evaluated thresholds (\u22653 vs. \u22654), compared PRIMARY with PI-RADS, and examined combined performance. Pooled sensitivity and specificity were estimated with a bivariate random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Thirteen studies (n=1974) were included. In biopsy-na\u00efve cohorts (6 studies), PRIMARY \u22653 achieved pooled sensitivity\/specificity of 90% (95% CI: 86%\u201393%) and 63% (95% CI: 57%\u201369%). In an expanded analysis of 9 studies regardless of prior biopsy, values were 87% (82%\u201390%) and 56% (46%\u201365%). Across 5 studies directly comparing thresholds, raising the cutoff from \u22653 to \u22654 reduced sensitivity from 89% to 81% but increased specificity from 53% to 72%. Three head-to-head studies showed comparable accuracy between PRIMARY and PI-RADS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>PRIMARY demonstrates high sensitivity and moderate specificity for csPCa, comparable to PI-RADS. In biopsy-na\u00efve men it shows robust performance, and combination with mpMRI further improves sensitivity. Threshold selection should reflect clinical intent, supporting PRIMARY as a tool for pre-biopsy risk stratification and integrated diagnostic workflows.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006309","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:00:49Z","timestamp":1770130849000},"page":"406-415","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8102-9654","authenticated-orcid":false,"given":"Felipe A.","family":"Mourato","sequence":"first","affiliation":[{"name":"Unidade de Diagn\u00f3stico por Imagem, Empresa Brasileira de Servi\u00e7os Hospitalares (EBSERH), Hospital das Cl\u00ednicas da Universidade Federal de Pernambuco (UFPE), Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3156-6379","authenticated-orcid":false,"given":"Luiza G.","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Universtiy of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5531-8900","authenticated-orcid":false,"given":"Miriana","family":"Mariussi","sequence":"additional","affiliation":[{"name":"Hospital Israelita Albert Einstein, S\u00e3o Paulo, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1936-1370","authenticated-orcid":false,"given":"Giovanni","family":"Torri","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Altmayer","sequence":"additional","affiliation":[{"name":"Department of Radiology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-8994","authenticated-orcid":false,"given":"Ur","family":"Metser","sequence":"additional","affiliation":[{"name":"University Medical Imaging Toronto, Joint Department of Medical Imaging (University Health, Network\/Sinai Health\/Women\u2019s College Hospital) and Department of Medical Imaging, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Veit-Haibach","sequence":"additional","affiliation":[{"name":"University Medical Imaging Toronto, Joint Department of Medical Imaging (University Health, Network\/Sinai Health\/Women\u2019s College Hospital) and Department of Medical Imaging, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9899-1612","authenticated-orcid":false,"given":"Simone","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Hospital das Cl\u00ednicas da UFPE, Universidade Federal de Pernambuco, Recife, PE, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6888-0417","authenticated-orcid":false,"given":"Andrei S.","family":"Purysko","sequence":"additional","affiliation":[{"name":"Abdominal Imaging Section and Department of Nuclear Medicine, Diagnostics Institute, Department of Urology and Colorectal Surgery, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8459-8369","authenticated-orcid":false,"given":"Sungmin","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Radiology, Oncologic Imaging Division, NYU Langone Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4761-8708","authenticated-orcid":false,"given":"Adriano B.","family":"Dias","sequence":"additional","affiliation":[{"name":"University Medical Imaging Toronto, Joint Department of Medical Imaging (University Health, Network\/Sinai Health\/Women\u2019s College Hospital) and Department of Medical Imaging, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"R1-20260401","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"R2-20260401","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s12885-020-06942-x","article-title":"Discrimination between clinical significant and insignificant prostate cancer with apparent diffusion coefficient\u2014a systematic review and meta analysis","volume":"20","author":"Meyer","year":"2020","journal-title":"BMC Cancer"},{"key":"R3-20260401","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"R4-20260401","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"R5-20260401","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"R6-20260401","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","article-title":"Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-na\u00efve men with elevated prostate-specific antigen: a large prospective multicenter clinical study","volume":"75","author":"Van Der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"R7-20260401","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"key":"R8-20260401","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Comparison of multiparametric magnetic resonance imaging\u2013targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA Oncol"},{"key":"R9-20260401","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1158\/1078-0432.CCR-20-4573","article-title":"Diagnostic performance of 18F-DCFPyL-PET\/CT in men with biochemically recurrent prostate cancer: results from the CONDOR phase III, multicenter study","volume":"27","author":"Morris","year":"2021","journal-title":"Clin Cancer Res"},{"key":"R10-20260401","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1148\/radiol.211824","article-title":"Effect of 18F-DCFPyL PET\/CT on the management of patients with recurrent prostate cancer: results of a prospective multicenter registry trial","volume":"303","author":"Metser","year":"2022","journal-title":"Radiology"},{"key":"R11-20260401","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1148\/radiol.211836","article-title":"Impact of 18F-DCFPyL PET on staging and treatment of unfavorable intermediate or high-risk prostate cancer","volume":"304","author":"Basso Dias","year":"2022","journal-title":"Radiology"},{"key":"R12-20260401","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"R13-20260401","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study","volume":"80","author":"Emmett","year":"2021","journal-title":"Eur Urol"},{"key":"R14-20260401","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1097\/RLU.0000000000005265","article-title":"Comparison of multiparametric MRI and the combination of PSMA plus MRI for the intraprostatic diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"49","author":"Brondani Torri","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R15-20260401","first-page":"1644","article-title":"The PRIMARY score: using intra-prostatic PSMA PET\/CT patterns to optimise prostate cancer diagnosis","volume":"63","author":"Emmett","year":"2022","journal-title":"J Nucl Med"},{"key":"R16-20260401","first-page":"291","article-title":"A comparative study on the diagnostic value of 18F-PSMA PET\/CT PRIMARY score and PSMA expression score for clinically significant prostate cancer","volume":"105","author":"Zhu","year":"2025","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"R17-20260401","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2967\/jnumed.122.265001","article-title":"A prostate-specific membrane antigen PET-based approach for improved diagnosis of prostate cancer in Gleason Grade Group 1: a multicenter retrospective study","volume":"64","author":"Zhang","year":"2023","journal-title":"J Nucl Med"},{"key":"R18-20260401","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/JU.0000000000004010","article-title":"Beyond Prostate Imaging Reporting and Data System: combining magnetic resonance imaging prostate imaging reporting and data system and prostate-specific membrane antigen\u2013positron emission tomography\/computed tomography PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer","volume":"212","author":"Emmett","year":"2024","journal-title":"J Urol"},{"key":"R19-20260401","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2967\/jnumed.123.266940","article-title":"Diagnostic performance of [18 F]AlF-thretide PET\/CT in patients with newly diagnosed prostate cancer using histopathology as reference standard","volume":"65","author":"Zang","year":"2024","journal-title":"J Nucl Med"},{"key":"R20-20260401","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1007\/s00330-025-11358-x","article-title":"Discordance between prostate MRI and PSMA-PET\/CT: the next big challenge for primary prostate tumor assessment?","volume":"35","author":"Woo","year":"2025","journal-title":"Eur Radiol"},{"key":"R21-20260401","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1021\/acs.molpharmaceut.3c00522","article-title":"Head-to-head comparison of68 Ga-PSMA-11 with68 Ga-P137 in patients with suspected prostate cancer","volume":"20","author":"Han","year":"2023","journal-title":"Mol Pharm"},{"key":"R22-20260401","first-page":"1","article-title":"Improved accuracy and reliability of PRIMARY scoring using delayed [68Ga] Ga-PSMA PET\/CT imaging","volume":"34","author":"Ak\u00e7ay","year":"2025","journal-title":"Mirt"},{"key":"R23-20260401","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/pros.24694","article-title":"Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography\/computed tomography-guided prostate biopsies: Enhancing targeting accuracy","volume":"84","author":"B\u00fcttner","year":"2024","journal-title":"Prostate"},{"key":"R24-20260401","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00259-023-06556-y","article-title":"Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET\/CT: a potential tool for selecting patients for active surveillance","volume":"51","author":"Akcay","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R25-20260401","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12149-024-02004-5","article-title":"PRIMARY scoring in 68Ga-PSMA PET\/CT: correlation with prostate cancer risk groups and its potential impact on active surveillance","volume":"39","author":"Uslu","year":"2025","journal-title":"Ann Nucl Med"},{"key":"R26-20260401","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2967\/jnumed.123.266164","article-title":"Reproducibility and accuracy of the PRIMARY score on PSMA PET and of PI-RADS on multiparametric MRI for prostate cancer diagnosis within a real-world database","volume":"65","author":"Emmett","year":"2024","journal-title":"J Nucl Med"},{"key":"R27-20260401","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/RLU.0000000000004951","article-title":"The PRIMARY score: diagnostic performance and added value compared with mri in detecting clinically significant prostate cancer","volume":"49","author":"Guo","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R28-20260401","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2967\/jnumed.123.266742","article-title":"The value of68 Ga-PSMA PET\/MRI for classifying patients with PI-RADS 3 lesions on multiparametric MRI: a prospective single-center study","volume":"65","author":"Shi","year":"2024","journal-title":"J Nucl Med"},{"key":"R29-20260401","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00259-024-06949-7","article-title":"Using a novel PSMA-PET and PSA-based model to enhance the diagnostic accuracy for clinically significant prostate cancer and avoid unnecessary biopsy in men with PI-RADS \u2264 3 MRI","volume":"52","author":"Li","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R30-20260401","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"key":"R32-20260401","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"R33-20260401","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"R34-20260401","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/sim.6115","article-title":"Statistics for quantifying heterogeneity in univariate and bivariate meta-analyses of binary data: the case of meta-analyses of diagnostic accuracy: Y. ZHOU AND N. DENDUKURI","volume":"33","author":"Zhou","year":"2014","journal-title":"Statist Med"},{"key":"R35-20260401","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1007\/s00259-021-05355-7","article-title":"Detection of clinically significant prostate cancer with 18F-DCFPyL PET\/multiparametric MR","volume":"48","author":"Metser","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R36-20260401","doi-asserted-by":"crossref","first-page":"e240401","DOI":"10.1148\/radiol.240401","article-title":"Use of molecular imaging to further investigate PI-RADS 3 lesions","volume":"311","author":"Turkbey","year":"2024","journal-title":"Radiology"},{"key":"R37-20260401","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/JU.0000000000000388","article-title":"Negative predictive value of prostate multiparametric magnetic resonance imaging among men with negative prostate biopsy and elevated prostate specific antigen: a clinical outcome retrospective cohort study","volume":"202","author":"Lo","year":"2019","journal-title":"J Urol"},{"key":"R38-20260401","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","article-title":"Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and meta-analysis","volume":"78","author":"Sathianathen","year":"2020","journal-title":"Eur Urol"},{"key":"R39-20260401","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1007\/s00330-017-4843-7","article-title":"A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer","volume":"27","author":"Zhang","year":"2017","journal-title":"Eur Radiol"},{"key":"R40-20260401","doi-asserted-by":"crossref","first-page":"e249024","DOI":"10.1148\/radiol.249024","article-title":"Erratum for: Update on PI-RADS version 2.1 diagnostic performance benchmarks for prostate MRI: systematic review and meta-analysis","volume":"312","author":"Oerther","year":"2024","journal-title":"Radiology"},{"key":"R41-20260401","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bju.16207","article-title":"Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy","volume":"133","author":"Geboers","year":"2024","journal-title":"BJU Int"},{"key":"R42-20260401","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1097\/RLU.0000000000004819","article-title":"Impact of 18F-DCFPyL PET\/MRI in selecting men with low-\/intermediate-risk prostate cancer for focal ablative therapies","volume":"48","author":"Basso Dias","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R43-20260401","first-page":"1923","article-title":"Clinical, pathologic, and imaging variables associated with prostate cancer detection by PSMA PET\/CT and multiparametric MRI","volume":"65","author":"Sonni","year":"2024","journal-title":"J Nucl Med"}],"updated-by":[{"DOI":"10.1097\/rlu.0000000000006667","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000}}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:01:09Z","timestamp":1775077269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006309"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006309","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-10-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}